Abstract Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor, death receptor 4 (DR4), have been implicated in the development of endothelial dysfunction and atherosclerosis. However, the signaling mechanism mediating DR4 activation leading to endothelial injury remains unclear. We recently demonstrated that ceramide production via hydrolysis of membrane sphingomyelin by acid sphingomyelinase (ASM) results in membrane raft (MR) clustering and the formation of important redox signaling platforms, which play a crucial role in amplifying redox signaling in endothelial cells leading to endothelial dysfunction. The present study aims to investigate whether TRAIL triggers MR clustering via lysosome fusion and ASM activation, thereby conducting transmembrane redox signaling and changing endothelial function. Using confocal microscopy, we found that TRAIL induced MR clustering and co-localized with DR4 in coronary arterial endothelial cells (CAECs) isolated from wild-type (Smpd1 +/+ ) mice. Furthermore, TRAIL triggered ASM translocation, ceramide production, and NADPH oxidase aggregation in MR clusters in Smpd1 +/+ CAECs, whereas these observations were not found in Smpd1 −/− CAECs.
Introduction
The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is expressed as a type II TNF ligand transmembrane protein which can be released as a vesicleassociated form or a soluble form. Five receptors for TRAIL have been identified. Two death receptors, DR4 and DR5, contain a death domain and transmit an apoptotic signal in response to TRAIL [1] . Two decoy receptors (DcR1 and DcR2) bind TRAIL without activation of the apoptotic machinery and seem to antagonize DR4 and DR5 [2] . Lastly, osteoprotegerin, originally identified as a regulator of osteoclastogenesis, was shown to bind TRAIL and function as a soluble TRAIL receptor [3] . Endothelial cells (ECs) express all TRAIL receptors including DR4 and DR5, and the activation of these receptors has been implicated in the regulation of EC activities including inflammation, proliferation, differentiation, and apoptosis [4] [5] [6] [7] [8] . For example, TRAIL down-modulated CCL8 and CXCL10 chemokine expression in human umbilical vein endothelial cells (HUVECs), which may contribute to its anti-inflammatory activity by counteracting the ability of TNF-α to promote leukocyte adhesion to ECs [5] . TRAIL induced apoptosis in HUVECs and human dermal and cerebral microvascular ECs [6] [7] [8] . In contrast, in HUVECs and human aortic ECs, TRAIL has been shown to activate the Akt and ERK1/2 pathways which may be associated with EC proliferation and differentiation [4] . Thus, these findings indicate that TRAIL may in parallel modulate apoptotic pathways as well as anti-apoptotic/pro-inflammatory pathways in ECs. Although these studies revealed the biological activities of TRAIL on ECs, it remains unknown whether and how this death factor indeed produces endothelial dysfunction when it acts on intact vessels for a short time.
Membrane rafts (MRs, previously as lipid rafts) are dynamic assemblies of cholesterol, lipids with saturated acyl chains, such as sphingolipids and glycosphingolipids, in the exoplasmic leaflet of the membrane bilayer, and cholesterol in the inner leaflet [9] . Recently, accumulating evidence suggest that MR clustering is a novel mechanism mediating and amplifying transmembrane signaling in response to various stimuli in a variety of cell types, including lymphocytes, endothelial cells, and neurons [10] [11] [12] . Clustered MRs form membrane signaling platforms, in particular, the ceramide-enriched platforms or macrodomains [9] . These membrane platforms can recruit or aggregate various signaling molecules such as small G proteins, tyrosine kinases, and phosphatases, resulting in the activation of different signaling pathways [9] . More recently, there are increasing evidence that MR clustering on the coronary arterial endothelial cells (CAECs) is an important initiating mechanism in endothelial injury in response to damaging factors such as death receptor agonists, inflammatory factors, and irradiation [9, 11, 13] . It has been shown that MR clustering recruits or aggregates redox signaling molecules such as NADPH oxidase subunits, gp91
phox , p47 phox , and Rac GTPase, resulting in the formation of a membrane signal amplification platform that activates and enhance production of O 2 −⋅ [11, 14] . These MR signaling platforms associated with O 2 −⋅ production have been referred as MR redox signaling platforms. The formation of such MR redox signaling platforms in the EC membrane is associated with ceramide production via lysosomal acid sphingomyelinase (ASM), which is translocated onto the plasma membrane via membrane proximal lysosome trafficking and fusion upon stimulation of death receptors [15] [16] [17] . Ceramides spontaneously fuse MRs into large ceramide-enriched membrane domains or platforms, which can serve as MR redox signaling platforms [9, 14] . TRAIL has been demonstrated to stimulate ceramide production through ASM and consequent formation of ceramide-enriched platforms in nonendothelial cells [18] . Based on these observations, the present study hypothesized that TRAIL stimulates O 2 −⋅ production through the formation of the MR redox signaling platforms in CAECs, leading to the impairment of endothelium-dependent vasodilation and endothelial injury. We used a series of molecular and physiological approaches to test this hypothesis. Particularly, the roles of ASM in lysosome fusion with the plasma membrane, the formation of MR redox signaling, as well as TRAIL-induced endothelial impairment were examined in primary cultured CAECs and small resistance arteries isolated from ASM-deficient mice, respectively.
Materials and methods

Isolation of mouse coronary arterial endothelial cells
The isolation and the characterization of mouse coronary endothelial cells were performed as described previously [19] . Briefly, the heart was excised with an intact aortic arch and immersed in a .0, HEPES; with 2 % antibiotics) was inserted into the aortic lumen opening while the whole heart remained in the ice-cold buffer solution. The opening of the needle was inserted deep into the heart close to the aortic valve. The aorta was tied with the needle as close to the base of the heart as possible. The infusion pump was started with a 20-mL syringe containing warm HBSS at a rate of 0.1 mL/min and the heart was then flushed for 15 min. HBSS was replaced with a warm enzyme solution (1 mg/mL collagenase type I, 0.5 mg/mL soybean trypsin inhibitor, 3 % BSA, and 2 % antibiotic-antimycotic) which was flushed through the heart at a rate of 0.1 mL/min. Perfusion fluid was collected at 30-, 60-, and 90-min intervals. At 90 min, the heart was cut with scissors and the apex was opened to flush out the cells that collected inside the ventricle. The fluid was centrifuged at 1,000 rpm for 10 min, the cell-rich pellets were mixed with the one of the media described below, and the cells were planted in 2 % gelatincoated six-well plates and incubated in 5 % CO 2 -95 % O 2 at 37°C. Medium 199-F-12 medium (1:1) with 10 % fetal bovine serum (FBS) and 2 % antibiotics was used for isolated endothelial cells. The medium was replaced 3 days after cell isolation and then once or twice each week until the cells grew to confluence. All biochemical studies in the present study were performed using CAECs of two to four passages. CAECs were identified by Dil-Ac-LDL staining as described previously [19, 20] . Six-week-old male C57BL/6J ASM-deficient (Smpd1 −/− ; Smpd1 is the gene symbol for the ASM gene sphingomyelin phosphodiesterase 1) mice and their wild-type littermates (Smpd1 +/+ ) were used in the present study; mouse genotyping was performed as described previously [21] . All animals were provided standard rodent chow and water ad libitum in a temperaturecontrolled room. All protocols were approved by the Institutional Animal Care and Use Committee of Virginia Commonwealth University (Richmond, VA).
Immunofluorescent microscopic analysis of MR clusters
CAECs were grown on poly-L-lysine-coated glass coverslips. After fixation with 4 % PFA, cells were incubated with Alexa Fluor 488-conjugated cholera toxin B (Alexa488-CTXB, 2 μg/mL, 2 h; Molecular Probes, Palo Alto, CA), which binds with the MR-enriched ganglioside G M1 . For dual-staining detection of the co-localization of MRs with DR4/5, ASM, ceramide, or gp91
phox , the cells were first incubated with Alexa488-CTXB and then with anti-DR4 or DR5 (1:250, BD Biosciences, San Jose, CA), anti-ASM (1:200, Santa Cruz, CA), anti-ceramide (1:200, Enzol Life Sciences, Farmingdale, NY), and anti-gp91 phox (1:200, BD Biosciences), respectively, which was followed by corresponding Alexa555-conjugated secondary antibodies (1:500, Invitrogen, Grand Island, NY). Then, colocalization was visualized with confocal microscopy. To accurately observe staining on the cell membrane, these cells were not permeabilized by excluding detergent in the washing and incubation buffer (phosphate-buffered saline, PBS). Clustering was defined as one or several intense spots or patches of fluorescence on the cell surface, while unstimulated cells displayed a homogenous distribution of the fluorescence throughout the membrane. The results were given as the percentage of cells showing a cluster as described previously [11, 22] .
Electron spin resonance detection of endothelial O 2 −⋅ Electron spin resonance was performed as described previously [11] . Gently collected CAECs were suspended in modified Krebs-HEPES buffer (in millimolars): NaCl, 99.01; KCl, 4.69; CaCl 2 , 1.87; MgSO 4 , 1.20; K 2 HPO 4 , 1.03; NaHCO 3 , 25.0; Na-HEPES, 20.0; and glucose, 11.1; pH 7.4) supplemented with deferoxamine (100 μmol/L, metal chelator). Approximately 1×10 6 cells were then incubated with TRAIL (100 ng/L) for 15 min; these cells were subsequently mixed with 1 mML of the O 2 −⋅ -specific spin trap 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine (CMH) in the presence or absence of manganesedependent superoxide dismutase (SOD, 500 U/mL; Sigma, St. Louis, MO). The cell mixture was then loaded in glass capillaries and immediately kinetically analyzed for O 2 −⋅ production for 10 min. The SOD-inhibited fraction of the signal was compared. The electron spin resonance spectrometry (ESR) settings were as follows: biofield, 3,350; field sweep, 60 G; microwave frequency, 9.78 GHz; microwave power, 20 mW; modulation amplitude, 3 G; 4,096 points of resolution; receiver gain, 100; and kinetic time, 10 min.
Vascular reactivity in in vitro perfused and pressurized small resistance arteries
Small mouse mesenteric arteries (third-order branch from the superior mesenteric artery, ∼100 μm) were dissected from 6-week-old mice in ice-cold physiological saline solution (PSS) with the following composition (in millimolars)-NaCl, 119; KCl, 4.7; CaCl 2, 1.6; MgSO 4, 1.17; NaH 2 PO 4, 1.18; NaHCO 3, 24; EDTA, 0.026; and glucose, 5.5 (pH 7.4)-and carefully cleaned off of fat and connective tissues under a dissection microscope. The dissected arteries were immediately transferred to a water-jacketed perfusion chamber and cannulated with two glass micropipettes at their in situ length as described previously [23] .
The outflow cannula was clamped and the arteries were pressurized to 60 mmHg and equilibrated in PSS at 37°C. PSS in the bath was continuously bubbled with a gas mixture of 95 % O 2 and 5 % CO 2 throughout the experiment. After a 1-h equilibration period, the arteries were precontracted with phenylephrine (PE, 1-10 nM) until an ∼50 % of decrease in resting diameter was reached. Once steady-state contraction was obtained, cumulative dose-response curves to the endothelium-dependent vasodilator acetylcholine (10
-10 −5 M) were determined by measuring changes in internal diameter. To induce endothelial impairment, small arteries were perfused with TRAIL (100 ng/mL) in the lumen and incubated for 1 h. All other drugs were added into the bath solution unless otherwise indicated. The vasodilator response was expressed as the percent relaxation of PE-induced pre-contraction based on changes in arterial internal diameter. The arteries were excluded from statistical analysis if the contractile response to PE was <40 % or dilator response to acetylcholine was <80 %. Internal arterial diameter was measured with a video system composed of a stereomicroscope (Leica MZ8), a charge-coupled device camera (KP-MI AU, Hitachi), a video monitor (VM-1220U, Hitachi), a video measuring apparatus (VIA-170, Boeckeler Instrument), and a video printer (UP890 MD, Sony). The arterial images were recorded continuously with a videocassette recorder (M-674, Toshiba).
Fluorescence resonance energy transfer analysis
Fluorescein isothiocyanate (FITC)/tetramethyl rhodamine isothiocyanate (TRITC) pairs were used for fluorescence resonance energy transfer (FRET) assay. CAECs were stained with FITC-conjugated anti-Lamp-1 (a lysosomal marker protein, 1:200; BD Biosciences) and TRITClabeled CTXB (TRITC-CTXB, 2 μg/mL, 2 h; Molecular Probes) as described above. An acceptor bleaching protocol was used to measure FRET between FITC/TRITC as described previously [22] . Briefly, after the pre-bleaching image was normally taken, the laser intensity at the excitement wavelength of the acceptor (TRITC) was increased from 50 to 98 % and continued to excite the cell sample for 2 min to bleach the acceptor fluorescence. After the intensity of the excitement laser for acceptor was adjusted back to 50 %, the post-bleaching image was taken for FITC. A FRET image was obtained by the subtraction of the pre-bleaching images from the post-bleaching images and given a dark blue color. After measuring the FITC fluorescence intensity of the pre-, post-, and FRET images, FRET efficiency was calculated through the following equation:
FM1-43 fluorescence quenching FM1-43 quenching was performed to detect lysosomal fusion to the plasma membrane as described previously [22] . CAECs were firstly loaded with 8 μM FM1-43 (Molecular Probes) for 2 h at 37°C. After washing with FBS-free medium, a FM1-43 quenching reagent, bromide phenol blue (BPB, 1 mM; Molecular Probes), was added in the extracellular medium. Cells were then stimulated with or without TRAIL and FM1-43 fluorescence scanned under a confocal microscopy (Olympus) with a low-power laser (l excitation 0 488 nm) to avoid fluorescent bleaching.
Statistics
Data are presented as the mean±SE. Significant differences between and within multiple groups were examined using ANOVA for repeated measures, followed by Duncan's multiple-range test. Student's t test was used to detect significant differences between two groups. A value of P<0.05 was considered statistically significant.
Results
TRAIL induces MR clustering in mouse CAECs
As shown in Fig. 1b showing that TRAIL dose-dependently increased MR clustering in CAECs. Since the optimum response of MR clustering was observed with 100 ng/mL TRAIL for 15 min, the same treatment was used in all experiments of the present study, if not otherwise mentioned. Figure 1c shows that DR4 colocalized with MR clusters in CAECs upon TRAIL stimulation, as detected by a number of large yellow patches or spots in overlaid image. In contrast, no significant colocalization was observed between the DR5 and MR clusters in CAECs with TRAIL treatment. The percentage of cells with intense yellow patches was summarized in Fig. 1d indicating that DR4, but not DR5, is involved in TRAILinduced MR clustering in CAECs.
TRAIL triggers ASM translocation and ceramide production in MR clusters
To investigate the spatial relation between MR clusters and ASM or ceramide, CAECs were stimulated with TRAIL and stained with Alexa488-CTX-and Alexa555-conjugated antibodies against ASM or ceramide. As shown in Fig. 2a-d , confocal microscopy revealed that ASM or ceramide co-localized in MR clusters in Smpd1 +/+ CAECs after TRAIL stimulation. However, such TRAIL-induced co-localization of ASM or ceramide with MR clusters was abolished in Smpd1 −/− CAECs.
TRAIL-induced NADPH oxidase aggregation in MR clusters requires ASM activity
We next investigate whether TRAIL induces the formation of MR redox signaling platforms by examining the aggregation of gp91 phox in MR clusters since gp91 phox is a major NADPH oxidase subunit in the plasma membrane of CAECs. As shown in Fig. 3a, b , TRAIL increased the co-localization between MRs and gp91 phox in Smpd1 +/+ CAECs, whereas TRAIL failed to increase such co-localization in Smpd1 −/− CAECs. 
TRAIL-induced lysosome trafficking to MRs in CAECs is ASM-dependent
We previously reported that lysosome-targeted ASM is able to traffic to and expose to the cell membrane surface, which may lead to MR clustering and NADPH oxidase activation in CAECs in response to various death receptor stimuli such as Fas ligand (FasL) and endostatin [11, 22] . Thus, we tested the hypothesis that TRAIL triggers lysosomal trafficking and fusion with the plasma membrane that is involved in ASM translocation, ceramide production, and MR redox signaling. As shown in Fig. 6a -c, TRAIL significantly increased the FRET (blue images) between FITC-Lamp-1 (lysosome marker) and TRITC-CTXB in Smpd1 +/+ CAECs, but not in Smpd1 −/− CAECs. As summarized in Fig. 6d , FRET efficiency between FITC-Lamp-1 and TRITC-CTXB was significantly increased in response to TRAIL stimulation in Smpd1 +/+ CAECs; however, such increase in FRET efficiency was not observed in Smpd1 −/− CAECs. ASM deficiency disrupts TRAIL-induced lysosome fusion with the plasma membrane We further investigated whether TRAIL-induced lysosomal trafficking to MRs is followed by lysosomal fusion with the plasma membrane and whether ASM is needed for this fusion process. CAECs were loaded with FM1-43, a fluorescence probe accumulated in lysosomes, and then incubated in fresh culture medium containing BPB, which binds FM1-43 and quenches its fluorescence. As shown in Fig. 7a , c, TRAIL induced a significant decrease in FM1-43 fluorescence in Smpd1 +/+ CAECs, indicating that the lysosome fuses with the plasma membrane and exposes its contents to extracellular spaces. However, TRAIL did not decrease FM1-43 in Smpd1 −/− CAECs (Fig. 7b, c) . These results indicated that TRAIL-induced lysosome fusion requires ASM activity.
Discussion
The present study demonstrates that death receptor ligand, TRAIL, triggers MR clustering, the formation of MR redox signaling platforms, the activation of NADPH oxidase, and the production of O 2 −⋅ in these platforms in isolated mouse
CAECs and induces impairment in endothelium-dependent vasodilation in isolated and pressurized small resistance arteries. In addition, ASM deficiency abolishes these TRAIL-induced signaling events in CAECs and impairment in arteries. These data suggest a novel role of lysosomal ASM-mediated MR redox signaling in the action of TRAIL on ECs and TRAIL-induced endothelial injury. MR clustering was first visualized on the cell membrane of CAECs by confocal microscopic analysis of CTXBpositive clusters. CTXB relatively specifically binds to MR-enriched ganglioside G M1 . The present study demonstrated that TRAIL dose-dependently increased MR clustering in primary cultured CAECs. Our findings are consistent with our previous studies demonstrating that MRs in the EC membrane are evenly distributed and CTXB staining displays a random punctuate staining pattern, whereas stimulation of ECs with death factors including FasL, TNF-α, or endostatin results in the formation of multiple "non-polarized" CTXB-positive patches [11] . Several previous studies also demonstrated that TRAIL can induce MR clustering in other cell types such as splenocytes and glioblastomas [18, 24, 25] . Together, these findings support the view that MR clustering may serve as a common mechanism for death receptor activation-coupled transmembrane signaling. Despite the presence of both TRAIL receptors DR4 and DR5 in MR microdomains in non-endothelial cells [24, 26, 27] , the present study only found DR4, but not DR5, in MR clusters after TRAIL stimulation, implicating that DR4 is activated by TRAIL and involved in consequent MR clustering in CAECs.
Next, we explored the mechanism by which TRAIL stimulates MR clustering. Ceramide spontaneously fuses MR microdomains to larger ceramide-enriched membrane domains. In this regard, ceramide has been proposed as the driving force in promoting MR clustering and subsequent signaling pathway in a variety of mammalian cells [9, 10, 28] . Our previous study has demonstrated that ASM activation serves as a triggering mechanism and driving force leading to the fusion of membrane proximal lysosomes into MR clusters on the cell membrane of CAECs in response to FasL, TNF-α, and endostatin [11, 16, 22] . In addition, TRAIL-induced MR clustering requires ASM-ceramide signaling in non-endothelial cells such as splenocytes and Jurkat leukemia cells [18, 29] . Consistently, the present study found that TRAIL significantly increased the enrichment of ASM and ceramide in the MR clusters, which was almost completely blocked in Smpd1 −/− CAECs. These results confirm that ASM aggregation and activation in MR clusters are essential to the MR clustering process in CAECs in response to TRAIL. Moreover, our findings further reinforce the concept that ASM activation is a common mechanism mediating MR clustering and corresponding signaling platform formations in ECs, in particular upon death receptor activation.
Increasing evidence suggests that MR clustering is able to promote the aggregation of NADPH oxidase subunits and to form MR redox signaling platforms after death receptor activation [11, [30] [31] [32] . By using confocal microscopy, the present study again demonstrated the formation of such MR redox signaling platforms, which were characterized by the aggregation of gp91 phox in MR clusters in Smpd1 +/+ CAECs in response to TRAIL activation. Interestingly, in Smpd1 view that in CAECs upon TRAIL stimulation, MR clustering is associated with lysosomal ASM-mediated ceramide production and serves as a driving force to assemble and activate NADPH oxidase on the EC membrane. To our knowledge, the present study, for the first time, reveals that TRAIL triggers lysosomal ASM-mediated MR redox signaling in ECs. Endothelial dysfunction in small resistance arteries is typically characterized by reduced or loss of endotheliumdependent vasodilation. To this end, the present study demonstrated that TRAIL impairs the endothelium-dependent vasodilator responses in isolated and pressurized small resistance arteries. Our results provide direct evidence that TRAIL produces an early action to induce endothelial dysfunction before detectable apoptotic effect. TRAIL has been reported to induce a detectable apoptosis only with long-term treatment of ECs (>15 h) [33, 34] . Given a relative resistance of ECs to apoptosis, functional impairment may represent one of the most important pathological actions of this apoptotic peptide in ECs. Additionally, TRAIL-induced impairment on vasodilator responses was not observed in ASM-deficient arteries, indicating that this inhibitory action of TRAIL is associated with the lysosomal ASM-mediated formation of MR clusters. Taken together, the results from CAECs and vessel preparation support the view that TRAIL-induced endothelial dysfunction is associated with increased O 2 −⋅ production from the lysosomal ASM-mediated formation of MR redox signaling platforms. We also found that acetylcholine-induced vasodilation was attenuated by inhibiting nitric oxide (NO) synthase, suggesting a NO-dependent vasodilation induced by acetylcholine (data not shown). Thus, increased endothelial O 2 −⋅ production by TRAIL could reduce the bioavailability of NO, resulting in the impairment of endotheliumdependent vasodilation, as shown in our previous studies and by others [11, 23, 35] . Lysosome trafficking to and fusion with the plasma membrane has been identified as an early signaling event in ECs upon death receptor activation [10, 22] . However, there is no direct evidence showing that ASM is actively involved in this fusion process. To this end, we performed more experiments to directly confirm and compare the fusion of lysosomes to te plasma membrane in Smpd1 +/+ and Smpd1
−/−
CAECs upon TRAIL stimulation. We found that TRAIL caused the co-localization of lysosome marker Lamp-1 with MR clusters on the cell membrane and increased FRET efficiency between MRs and Lamp-1 in Smpd1 +/+ CAECs. Because FRET can only occur between molecules in a distance within a 10-nm range, increased FRET between Lamp-1 and the MR component ganglioside G M1 should indicate that some lysosomes are indeed fused into the cell membrane within MR clusters. We also provided direct evidence that TARIL triggers lysosome fusion in living cells using FM1-43, a lysosome-specific fluorescence which can be reversibly quenched by BPB. In the quenching experiments, TRAIL was found to cause a decrease in the FM1-43 fluorescence in Smpd1 +/+ CAECs, which was attributable to TRAIL-stimulated lysosome fusion with the plasma membrane, allowing BPB to enter the lysosomes to quench FM1- induced lysosome fusion requires ASM activity. Our findings are consistent with recent studies showing that ASM was required for the efficient phagolysosomal fusion [36, 37] . However, lysosomal fusion still occurs in ASM-deficient lymphoblasts, but endocytosis and plasma membrane repair were impaired in these cells [38] . Moreover, a recent study showing TCR-triggered fusion of lysosome-type lytic granules is not altered in ASM-deficient cytotoxic T lymphocytes compared to wild-type cells; in contrast, ASM deficiency results in an impaired expulsion of the vesicular contents [39] . Most recently, it has been demonstrated that oxidative stress triggered by H 2 O 2 induces Ca 2+ -dependent, but ASM-independent, lysosome fusion with the plasma membrane in Jurkat T cells [40] . It is possible that DR4 activation and H 2 O 2 trigger different pathways to activate the ASM, for instance cleavage vs. oxidation, and that these different pathways also show a selective requirement of the ASM for the fusion process. Nonetheless, these studies suggest that the lysosome fusion process may involve ASM-dependent or ASM-independent mechanisms which depend on the cell types and the specific treatment used.
The present study did not attempt to further explore the precise mechanism of how ASM contributes to the lysosome fusion process in CAECs. It is possible that TRAIL induces a small amount of ceramide production (kindling ceramide) via the activation of ASM in the plasma membrane. This kindling ceramide may trigger lysosome trafficking and fusion to MR microdomains, which results in the translocation of more lysosomal ASM onto MRs, producing bonfire ceramide. Such bonfire ceramide may function as a driving force to promote MR clustering and the formation of important signaling platforms, which may further enhance lysosome trafficking and the fusion process [10, 41] . Nonetheless, this kindling and bonfire ceramide hypothesis in lysosome/MR-associated signaling needs to be tested in future studies. In summary, the present study was the first to demonstrate that TRAIL is able to induce endothelial dysfunction as an early-stage acute action, which is associated with the assembly and activation of NADPH oxidase in MR clusters. The clustered MRs, together with the activated NADPH oxidase, constitute a redox signaling platform mediating the pathological actions of TRAIL on the vascular endothelium. Finally, we explored an essential role of ASM in the initiation of lysosome trafficking to and fusion with the plasma membrane in CAECs. The findings from the present study might increase our understanding of how MR redox signaling platforms are formed in ECs. Since death receptor ligands including TRAIL are implicated in the pathogenesis of various cardiovascular diseases such as atherosclerosis, the formation of the redox signaling platforms on the membrane of ECs may mediate the early response of the death receptors, leading to endothelial dysfunction in vivo and to the development of these diseases. 
